AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 16 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $36,674,000 | +2.6% | 52,392,000 | 0.0% | 0.37% | -6.6% |
| Q1 2019 | $35,758,000 | -18.6% | 52,392,000 | 0.0% | 0.39% | -24.9% |
| Q4 2018 | $43,937,000 | +11.1% | 52,392,000 | 0.0% | 0.52% | +16.3% |
| Q3 2018 | $39,556,000 | +16.2% | 52,392,000 | 0.0% | 0.45% | +5.9% |
| Q2 2018 | $34,055,000 | -15.6% | 52,392,000 | 0.0% | 0.42% | -26.1% |
| Q1 2018 | $40,342,000 | -3.4% | 52,392,000 | +1.5% | 0.57% | -3.9% |
| Q4 2017 | $41,765,000 | +0.1% | 51,642,000 | 0.0% | 0.60% | -4.3% |
| Q3 2017 | $41,704,000 | -99.9% | 51,642,000 | +21.1% | 0.62% | +12.4% |
| Q2 2017 | $35,019,742,000 | +128412.8% | 42,642,000 | +26.8% | 0.56% | +20.7% |
| Q1 2017 | $27,250,000 | – | 33,642,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 24,200,000 | $17,243,000 | 10.27% |
| Context Capital Management, LLC | 3,910,000 | $2,830,000 | 3.10% |
| Telemetry Investments, L.L.C. | 4,500,000 | $3,206,000 | 1.81% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 65,567,000 | $47,208,000 | 0.84% |
| UBS OCONNOR LLC | 30,500,000 | $21,579,000,000 | 0.42% |
| K2 PRINCIPAL FUND, L.P. | 6,000 | $4,350,000 | 0.41% |
| Tekla Capital Management LLC | 13,000,000 | $9,263,000 | 0.40% |
| Baker Brothers Advisors | 26,517,000 | $19,103,000 | 0.19% |
| FALCON POINT CAPITAL, LLC | 1,500,000 | $1,069,000 | 0.14% |
| Orbimed Advisors | 8,000,000 | $5,976,000 | 0.08% |